Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,220 | 1,561 | 987 | 827 | 4,045 |
| Receivables | 422 | 2,114 | 1,840 | 711 | 1,151 |
| Other current assets | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $4,643 | $3,675 | $2,827 | $1,538 | $5,197 |
| Non-Current Assets | |||||
| PPE Net | 1 | 11 | N/A | 11 | 15 |
| TOTAL | $1 | $11 | $N/A | $11 | $15 |
| Total Assets | $4,644 | $3,677 | $2,829 | $1,541 | $5,204 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 186 | 0 | 2 | 0 | 2,215 |
| Accounts payable and accrued liabilities | 7,873 | 8,368 | 9,607 | 7,062 | 4,263 |
| Other current liabilities | N/A | 859 | 446 | 359 | 779 |
| TOTAL | $8,059 | $9,227 | $10,055 | $7,421 | $7,257 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,059 | $9,227 | $10,055 | $7,421 | $7,257 |
| Shareholders' Equity | |||||
| Retained earnings | -145,609 | -143,025 | -145,203 | -142,523 | -125,698 |
| Other shareholders' equity | -9,032 | -9,242 | -6,073 | -6,470 | -7,741 |
| TOTAL | $-3,415 | $-5,550 | $-7,226 | $-5,880 | $-2,053 |
| Total Liabilities And Equity | $4,644 | $3,677 | $2,829 | $1,541 | $5,204 |